Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
BioMarin Pharmaceuticals
BMRN
$12.6B
| $33.6M | 0.02% |
362,631
+99,211
| +38% | +$9.34M |
|
|
702
PUT
Synchrony
SYF
$26B
| $33.5M | 0.02% |
1,198,100
-3,101,600
| -72% | -$85.2M |
|
703
CALL
Southern Company
SO
$104B
| $33.3M | 0.02% |
650,000
-138,000
| -18% | -$7.27M |
|
704
CALL
Helmerich & Payne
HP
$4.25B
| $33.3M | 0.02% |
494,900
-542,800
| -52% | -$34.1M |
|
|
P
705
DELISTED
Pandora Media Inc
P
| $33.2M | 0.02% |
2,316,701
+178,529
| +8% | +$2.41M |
|
|
SKX
706
PUT
DELISTED
Skechers
SKX
| $33.2M | 0.02% |
1,447,800
+631,500
| +77% | +$16.1M |
|
707
PUT
Best Buy
BBY
$18.4B
| $33.1M | 0.02% |
867,400
-53,200
| -6% | -$1.87M |
|
708
CALL
Coty
COTY
$2.46B
| $33M | 0.02% |
1,404,700
+1,329,600
| +1,770% | +$35.1M |
|
709
CALL
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.53B
| $33M | 0.02% |
1,007,500
-266,500
| -21% | -$8.62M |
|
|
MJN
710
PUT
DELISTED
Mead Johnson Nutrition Company
MJN
| $32.9M | 0.02% |
416,700
+79,600
| +24% | +$6.79M |
|
711
CALL
Air Products & Chemicals
APD
$68.2B
| $32.9M | 0.02% |
236,631
+24,539
| +12% | +$3.4M |
|
712
CALL
Simon Property Group
SPG
$71.4B
| $32.8M | 0.02% |
158,600
-238,800
| -60% | -$51.8M |
|
713
CALL
VanEck Oil Services ETF
OIH
$1.94B
| $32.8M | 0.02% |
56,010
-35,480
| -39% | -$20M |
|
714
NetEase
NTES
$78.7B
| $32.8M | 0.02% |
680,920
+9,245
| +1% | +$393K |
|
|
SE
715
CALL
DELISTED
Spectra Energy Corp Wi
SE
| $32.8M | 0.02% |
766,200
-126,700
| -14% | -$4.82M |
|
716
CALL
Zillow
Z
$8.33B
| $32.7M | 0.02% |
944,700
-611,300
| -39% | -$21.9M |
|
|
STJ
717
DELISTED
St Jude Medical
STJ
| $32.3M | 0.02% |
405,557
+396,722
| +4,490% | +$32M |
|
718
State Street SPDR S&P Biotech ETF
XBI
$11.5B
| $32.3M | 0.02% |
+486,698
| New | +$30.1M |
|
719
CALL
Kohl's
KSS
$2.08B
| $32.2M | 0.02% |
736,900
+189,200
| +35% | +$7.93M |
|
720
PUT
International Paper
IP
$21.7B
| $32.1M | 0.02% |
707,414
+76,348
| +12% | +$3.37M |
|
|
RHT
721
CALL
DELISTED
Red Hat Inc
RHT
| $32M | 0.02% |
396,300
+28,200
| +8% | +$2.1M |
|
|
ENDP
722
PUT
DELISTED
Endo International plc
ENDP
| $32M | 0.02% |
1,588,600
+92,000
| +6% | +$1.83M |
|
|
TSRO
723
PUT
DELISTED
TESARO, Inc.
TSRO
| $32M | 0.02% |
319,300
+212,900
| +200% | +$19.9M |
|
724
CALL
Range Resources
RRC
$9.64B
| $31.9M | 0.02% |
824,000
+142,700
| +21% | +$5.77M |
|
|
XYZ
725
CALL
Block Inc
XYZ
$48.9B
| $31.8M | 0.02% |
2,723,100
+1,660,700
| +156% | +$18.1M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.57B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,275 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.